[Asia Economy Reporter Hyunseok Yoo] Classys announced on the 3rd that it has been selected as a Global Small Giant by the Ministry of SMEs and Startups. Designated companies can receive support related to overseas marketing, research and development, production processes, and quality for four years from this year through 2024.


Classys is directly conducting research and development, production, and sales to lead the globalization of the aesthetic medical device market. Its flagship product, Shurink, is forming global trends based on its popularization in Korea, and export amounts are increasing accordingly. The company is also expanding its product portfolio with items launched for the body market such as Alpah (CLATUU Alpah), Scizer, and Ulfit.


A company official stated, "About 45% of Classys' total sales come from Korea, while exports account for 55%, so the overseas proportion is slightly higher. Among these, annual sales in Brazil have exceeded 9 billion KRW, showing a high potential for popularization similar to Korea." He added, "We will strengthen global marketing and increase overseas market share based on various support benefits provided to Global Small Giants."



Meanwhile, Classys' export amount in 2020 was 41.9 billion KRW, with sales increasing compared to the previous year despite the COVID-19 situation. According to the company, this is a point in time when demand for new aesthetic medical devices realized through Classys' technological capabilities is beginning to increase significantly, rather than being affected by fluctuations in the number of confirmed cases.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing